Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02093182

An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm

A Retrospective, Open-Label, Non-Randomized, Study Designed to Evaluate the Correlation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Vasospasm Patients After Sub Arachnoid Hemorrhage

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
HeadSense Medical · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The lack of a precise diagnostic technique for cerebral vasospasm associated with traumatic brain injury (TBI) limits the ability to detect and treat this phenomenon. Surveillance Transcranial Doppler ultrasonography (TCD) is the main medical instrument that is utilized to monitor radiographic vasospasm following TBI, yet has its drawbacks such as inaccuracy, highly operator dependent and more. HS-1000 device, an investigational vasospasm detection device, has the potential to safely diagnose and assess vasospasm with minimal discomfort to patients, allowing a new modality for vasospasm measurement tool. We aim to evaluate the correlation between the collected and analyzed data from the HS-1000 device and the clinical findings from the TCD tests post-subarachnoid hemorrhage (SAH) patients.

Conditions

Timeline

Primary completion
2014-10-01
Completion
2014-10-01
First posted
2014-03-20
Last updated
2016-12-22

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02093182. Inclusion in this directory is not an endorsement.